16-04-2024 20:00 via bizjournals.com

Cullinan rebrands with $280M private offering, expands beyond cancer

The change comes as Cullinan said on Tuesday it plans to continue development of its drug, CLN-978, in autoimmune diseases rather than oncology.

Read more »

At Biogen, CEO Viehbacher got less total pay than many executives last year

WeWork puts largest Boston lease on chopping block

Mass. climate bank rolls out first loan program to help homeowners

Startup that aims to revolutionize cataract surgery raises $17.5M

X4 Pharmaceuticals’ bet on drug for ultra-rare disease pays off with FDA approval

Tripadvisor CEO's total compensation plunges 86% in 2023

Five Things: Cannabis tax refunds, MassDevelopment's CEO, Wormtown Brewery sells and the joys of hiring

After 'reset,' Flagship startup lands $1.8B Bristol Myers Squibb deal

Here are 10 healthtech startups joining Northeastern’s Roux Institute in Maine

Jack’s Abby to take over Wormtown Brewery; purchase to close early summer

Dan Rivera steps down as MassDevelopment CEO

WeWork may close another location, this time near South Station

Form D Friday: WPI alum raises $6M for infrastructure tech startup

Mass. health czar: State is 'prepared' for whatever comes next with Steward